The relationship between pre-diagnostic levels of IGF-I and IGF binding protein-3 (IGFBP-3) and breast cancer risk was examined in a meta-analysis of data from 17 prospective studies conducted in 12 countries (Endogenous Hormones and Breast Cancer Collaborative Group, 2010). The gene discussed is IGF1; the disease is breast carcinoma.